Immunai Acquires Swiss Company Nebion To Expand Its Platform for Target Discovery and Drug Development
The company welcomes the Nebion team, Moderna co-founder Robert Langer as a Board Member, and world-renowned immunologist Jacques Banchereau…
biotech